References
- Bailer , A J . 1988 . Testing for the equality of area under the curves when usingdestructive measurement techniques . J Pharmacokinet Biopharm , 16 ( 3 ) : 303 – 309 .
- Nedelman , J R , Gibiansky , E and Lau , D TW . 1995 . Applying Bailer's method for AUC confidence intervals tosparse sampling . Pharm Res , 12 ( 1 ) : 124 – 128 .
- Yeh , C . 1990 . “ Estimation and significant tests of area under the curve derived from incomplete blood sampling ” . In American Statistical Association Proceedings of the BiopharmaceuticalSection 74 – 81 .
- Yeh , K C and Small , R D . 1989 . Pharmacokinetic evaluation of stable piecewise cubic polynomialsas numerical integration functions . J Pharmacokinet Biopharm , 17 ( 6 ) : 721 – 740 .
- Nedelman , J R and Gibiansky , E . 1996 . The variance of a better AUC estimator for sparse, destructivesampling in toxicokinetics . J Pharm Sci , 85 ( 8 ) : 884 – 885 .
- Nedelman , J R and Jia , X . 1998 . An extension of Satterthwaite's approximation applied topharmacokinetics . J Biopharm Stat , 8 : 317 – 328 .
- Satterthwaite , F E . 1946 . An approximate distribution of estimates of variance components . Biometrics Bull , 2 : 110 – 114 .
- Pearson , E S and Hartley , H O . 1958 . Biometrika Tables for Statisticians,Vol. 1 Vol. 1 , 179 London : CambridgeUniversity Press .
- Westlake , W J . 1973 . “ The design and analysis of comparative blood-level trials ” . In Current Concepts in the Pharmaceutical Sciences Edited by: Swarbrick , J . 159 – 179 . Philadelphia : Lea andFebiger .
- " US Food and Drug Administration ." Guidance, Statistical Procedures for Bioequivalence Studies Usinga Standard Two-Treatment Crossover Design , US Food and Drug Administration 1992
- Dunnett , C W . 1955 . A multiple comparisons procedure for comparing several treatmentswith a control . J Am Stat Assoc , 50 : 1096 – 1121 .
- Mosteller , F and Tukey , J W . 1977 . “ Ch. 8 ” . In Data Analysis and Regression Reading, MA : Addison-Wesley .
- Miller , R G . 1974 . The jackknife: A review . Biometrika , 61 : 1 – 15 .
- March 1, 1995 . International Conference on Harmonization . Guidelines on Dose Selection for Carcenogenicity Studies ofPharmaceuticals , 60 ( 40 ) : 11278 – 11281 . Federal Register